Cargando…
Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma
Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults and around half of the patients develop metastasis and die shortly after because of the lack of effective therapies for metastatic UM. Consequently, new therapeutic approaches to this disease are welcome. In this re...
Autores principales: | Milán Rois, Paula, Latorre, Alfonso, Rodriguez Diaz, Ciro, del Moral, Álvaro, Somoza, Álvaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352695/ https://www.ncbi.nlm.nih.gov/pubmed/31105250 http://dx.doi.org/10.3390/biomimetics3040028 |
Ejemplares similares
-
The Role of LncRNAs in Uveal Melanoma
por: Milán-Rois, Paula, et al.
Publicado: (2021) -
Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma
por: Yang, Chun, et al.
Publicado: (2021) -
Water Soluble Iron-Based Coordination Trimers as Synergistic Adjuvants for Pancreatic Cancer
por: Cordani, Marco, et al.
Publicado: (2021) -
Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
por: Liu, Jinlu, et al.
Publicado: (2021) -
The Role of Non-Coding RNAs in Uveal Melanoma
por: Bande, Manuel, et al.
Publicado: (2020)